SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
NY |
Click to view... | Registrant | About | Filings | Files | Relationships | Names | Topics | Web | ||||||||||||||||||||||||||||||
First | Latest Filing | Filing | Issuer / Subject | ||||||
---|---|---|---|---|---|---|---|---|---|
2/14/23 | 2/14/24 | SC 13G |
| Acrivon Therapeutics, Inc. | |||||
5/22/23 | SC 13G | InspireMD, Inc. |
As Of | | Quarter (Ended) | Holdings Form 13F | Assets (Millions) | Reporting Manager and Related Manager Manager with whom Investment Discretion is Shared | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/24 | 12/31/23 | 3,054 | $52,990,664 | Marshall Wace, LLP | ||||||||||
Not Allocated... |
| Marshall Wace North America L.P. | ||||||||||||
and 1 Other Manager |
Latest Filing | Affiliate | Filings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Type | As Party | |||||||||||
5/15/23 | 13F-NT | Filer:¹ | Marshall Wace Asia Ltd. | 11 | ||||||||
11/15/21 | 13F-HR | Filer:¹ | Marshall Wace, LLP | 4 | ||||||||
Total: | 15 | |||||||||||
__________ | ||||||||||||
|
Latest Filing | Filing Agentª, Registrant or SEC — SEC # | Filings | |||||||
---|---|---|---|---|---|---|---|---|---|
Type | |||||||||
2/14/24 | 13F-NT | Marshall Wace, LLP — 1318757 | 8 | ||||||
2/14/24 | SC 13G/A |
| Schulte Roth & Zabel LLP/FA — 902664 | 3 | |||||
5/15/23 | 13F-NT | No Filing Agent: Self-filed — 1325091 | 75 | ||||||
5/14/14 | 13F-NT | Marshall Wace Asia Ltd. — 1519964 | 1 | ||||||
8/12/05 | 13F-HR |
| Morgan Stanley & Co. Inc./NY — 728672 | 2 | |||||
Total: | 89 | ||||||||
__________ ª Proprietary to SEC Info℠: The SEC does not publish the names of SEC Filing Agents. |